News
CRITICARE, February 15-19, Pune, India
January 24 2012
Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA
January 24 2012
MEDLAB, Arab Health, January 23-26, Dubai, UAE
January 16 2012
An addition to the Obesity and Type 2 Diabetes antibody portfolio
December 22 2011
Better kidney markers ahead?
December 05 2011
New NGAL.com website launched
November 24 2011
MEDICA, November 16-19, Düsseldorf, Germany
October 26 2011
ASN Kidney Week, November 8-13, Pennsylvania, Philadelphia, USA
October 20 2011
ESICM 2011, October 1-5, Berlin, Germany
September 06 2011
AACC Clinical Lab Expo, July 24-28, Atlanta
July 04 2011
ToxExpo, March 7-11, Salt Lake City, Utah
February 16 2010 by Ana Belén Enfedaque Buisán
BioPorto Diagnostics joins forces with its partner in the US and Canadian markets, ALPCO Diagnostics, in promoting the animal and human NGAL product line at ToxExpo.
ToxExpo is held in connection with the annual meeting of Society of Toxicology, the largest toxicology meeting attracting more than 6,500 toxicologists from around the world.
BioPorto's NGAL product line gives the pharmaceutical industry a unique tool to assess the renal status of a variety of animals used in safety testing of new drug candidates.
Jakob Ohm Eriksen, Product Manager Pharma Diagnostics, will welcome you at ALPCO Diagnostics booth nr. 642.
For product related inquiries or to set up an appointment, please contact him at joe@bioporto.com.
For further information about ToxExpo: http://www.toxicology.org/AI/MEET/AM2010/
